Gregory Burshtein - 07 May 2026 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Reporting relationship: Chief of R&D
Issuer ticker: ENTX
Reported as of: 07 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 May 2026, 16:26:41 UTC
Prior SEC filing: 18 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Dana Yaacov-Garbeli, Attorney-in-fact

Key filing fact

Gregory Burshtein filed Form 4 for Entera Bio Ltd. (ENTX) on 08 May 2026.

Key facts

This page summarizes Gregory Burshtein's Form 4 filing for Entera Bio Ltd. (ENTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 16:26.

Change

Previous filing in this sequence was filed on 18 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026002 Primary reporting owner

Burshtein Gregory

Relationship: Chief of R&D
Address: KIRYAT HADASSAH, MINRAV BUILDING,, FIFTH FLOOR, JERUSALEM, ISRAEL
Signature: /s/ Dana Yaacov-Garbeli, Attorney-in-fact
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENTX transaction

Ordinary Shares, par value NIS 0.0000769 per share

Award

Transaction value
Shares: +87,591
Change %: +86%
Price: $0.000000^*
Shares after: 189,033
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026.